Challenges in proliferative vitreoretinopathy: is biological therapy a solution?

Ferro Desideri, Lorenzo; Zandi, Souska; Zinkernagel, Martin S; Anguita, Rodrigo (2023). Challenges in proliferative vitreoretinopathy: is biological therapy a solution? Expert opinion on biological therapy, 23(10), pp. 937-939. Taylor & Francis Group 10.1080/14712598.2023.2248881

[img] Text
Challenges_in_proliferative_vitreoretinopathy_is_biological_therapy_a_solution.pdf - Accepted Version
Restricted to registered users only
Available under License Publisher holds Copyright.
Download (1MB) | Request a copy

Item Type:

 Journal Article (Further Contribution)

Division/Institute:

 04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Ophthalmology
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > Forschungsbereich Augenklinik > Forschungsgruppe Augenheilkunde
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR)

UniBE Contributor:

 Ferro Desideri, Lorenzo, Zandi, Souska Sophie, Zinkernagel, Martin Sebastian, Anguita Henríquez, Rodrigo Andrés

Subjects:

 600 Technology > 610 Medicine & health

ISSN:

 1744-7682

Publisher:

 Taylor & Francis Group

Language:

 English

Submitter:

 Pubmed Import

Date Deposited:

 16 Aug 2023 15:57

Last Modified:

 06 Oct 2023 00:14

Publisher DOI:

 10.1080/14712598.2023.2248881

PubMed ID:

 37581430

Uncontrolled Keywords:

 PVR PVR classification, methotrexate, corticosteroids Proliferative vitreoretinopathy therapeutic challenges

BORIS DOI:

 10.48350/185488

URI:

 https://boris.unibe.ch/id/eprint/185488

Actions (login required)

Edit item Edit item
Provide Feedback